Ultra-low-temperature (ULT) freezers are medical cold chain devices that are becoming increasingly important in the life sciences sectors due to the need for precise ultra-low storage conditions for delicate biological samples, reagents, and materials vital for drug development and strict quality control measures.
Image Credit: B Medical Systems S.à r.l
ULT freezers are designed to maintain temperatures in the region of -80 °C, ensuring the stability, integrity, and reliability of biological substances and chemical compounds sensitive to even minor temperature fluctuations.
ULT freezers are essential in life science applications, primarily supporting long-term studies and experimental consistency. For research involving biological products, such as cell lines, enzymes, DNA, and RNA, ultra-low temperatures prevent molecular degradation and enzymatic activity that can influence experimental results over time.
For drug development, ULT freezers store critical reagents and intermediates, ensuring that all drug formulation and testing stages are consistent, accurate, and unaffected by temperature fluctuations.
ULT freezers are also essential in research and clinical settings where high-value biological samples—often collected over years of research—may be required for future analysis and testing.
However, traditional ULT freezers have a high energy demand due to the constant and intense cooling necessary for maintaining ultra-low temperatures. This poses financial and sustainability challenges for institutions.
In response to these issues, B Medical Systems has introduced the U701V, a new ULT freezer that balances energy efficiency with exceptional performance.
The U701V by B Medical Systems
The U701V provides innovative features that balance the requirements of intensive use with reliable performance. Variable-speed compressors conserve the unit’s energy while enhancing temperature uniformity more efficiently than conventional ULT freezers with fixed-speed compressors.
The U701V employs natural hydrocarbon refrigerants, significantly reducing the environmental impact and aligning the unit with global sustainability goals. This ensures the U701V complies with emissions standards, enabling users to meet regulatory requirements for environmental preservation.
The medical cold chain solution also enables fast recovery times, guaranteeing the consistent ultra-low temperatures crucial for pharmaceutical samples. This capability is especially valuable in laboratories requiring frequent access, ensuring sample integrity over long storage periods.
The U701V operates quietly, maintaining a comfortable working environment, and has an energy-efficient design that lowers the total cost of ownership, making it a sustainable investment for laboratories aiming to cut costs and reduce environmental footprint.
The adjustable temperature range from -86 °C to -20 °C offers flexibility for users who can set the optimal storage conditions for various needs. This allows institutions with less strict temperature requirements to further reduce energy consumption.
Studies have shown that adjusting the temperature from -80 °C to -70 °C can decrease energy consumption without compromising the quality of specific stored samples.
Conclusion
The U701V combines innovation with a commitment to sustainability, meeting the ever-changing needs of the pharmaceutical industry.
The U701V’s advanced variable-speed compressor, environmentally friendly natural refrigerants, and energy-efficient design address the industry's dual priorities, reducing environmental impact and maintaining rigorous storage standards for sensitive materials.
The U701V enables laboratories to optimize workflow efficiency and environmental footprint by lowering energy consumption, enhancing temperature stability and minimizing operational noise, making the unit an ideal choice for facilities aiming to modernize and align with sustainable practices.
The U701V’s balance of energy savings, reduced ecological impact and operational cost reductions is an excellent example of B Medical Systems' dedication to advancing technology to benefit the scientific community and the planet.
As the industry moves toward greener solutions, the U701V represents a benchmark for sustainable cold storage technology, supporting the wider goal of achieving long-term advancement in research and environmental responsibility.
About B Medical Systems S.à r.l
B Medical Systems S.à r.l (formely Dometic/Electrolux) is a global manufacturer and distributor of medical cold chain solutions. Based in Hosingen, Luxembourg, the company was founded in 1979, when WHO approached the Swedish manufacturing giant Electrolux to provide a solution to safely store and transport vaccines around the world. Across the 3 major business portfolios of Medical Refrigeration, Blood Management Solutions, and Vaccine Cold Chain, the company currently offers 100+ models. B Medical Systems’ major products include Laboratory Refrigerators, Laboratory Freezers, Pharmacy Refrigerators, Ultra-Low Freezers, Plasma Freezers, Contact Shock Freezers, Vaccine Refrigerators (Ice-Lined Refrigerators and Solar Direct Drive Refrigerators), and Transport Boxes. All products have integrated 24/7 temperature monitoring capabilities that further ensure that these products offer the highest level of safety and reliability.
Throughout its over 40 years of experience, the company has created innovative solutions to store and transport pharmaceuticals, blood components, laboratory specimens, vaccines, etc across the world safely and reliably. Its commitment to supporting health institutions, governments, and NGOs has not only saved innumerable lives but helped entire communities develop and prosper.
The company’s products are essential to hospitals, health centres, blood banks, laboratories and more, as their great reliability and efficiency ensures that any biological requiring cold storage can indeed be stored safely at its intended temperature. As modern medicine becomes more complex and very often requires the use of unstable compounds or produces thermosensitive solutions, B Medical Systems medical cold chain equipment provides the peace of mind scientists and healthcare workers need in their day-to-day life.
Moreover, as the established market leader in the Vaccine Cold Chain for the past 40 years, B Medical Systems has provided equipment to support its partners in vaccinating more than 350 million children in developing countries. Through its long-lasting relationships with global humanitarian organisations such as UNICEF, the WHO, Gavi, Health Ministries, etc., B Medical Systems has installed more than five hundred thousand units across 140+ countries across the world for safely storing and transporting vaccines, medicines, blood and other samples.
During the COVID-19 pandemic, B Medical Systems has been actively supporting governments worldwide in the formation of their vaccine responses, by supporting the establishment of a reliable and versatile vaccine cold chain able to meet any storage temperature requirement.
B Medical Systems is also one of the first few companies in the world to receive EU MDR certification for its active refrigeration product lines across medical refrigeration and blood management business lines. B Medical Systems is also one of the few companies in the world to have an end-to-end refrigeration solution certified by EU MDR, US FDA and WHO PQS.
B Medical Systems Corporate Video EN (2018)
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.